Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies

NCT02447926 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02447926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02447926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies
Lead sponsor
Northwestern University
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2014
Completion date
July 31, 2016
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage liver disease